CDON pseudogene 3 (CDONP3)

CDON pseudogene 3 is a predicted or annotated pseudogene corresponding to the CDON gene. The functional CDON gene encodes a cell surface receptor implicated in muscle development and signal transduction, but the pseudogene variant does not code for a functional protein. Pseudogenes like CDONP3 usually arise through duplication or retrotransposition events and typically lack protein-coding potential, though some may be transcribed and play a role in gene regulation at the RNA level in rare instances. There is no evidence that CDONP3 is involved in disease, serves as a drug target or biomarker, or is being actively researched as a therapeutic target. The term "CDON pseudogene 3" (CDONP3) does not map to a currently recognized protein-coding gene, receptor, enzyme, or validated therapeutic target. The gene name follows standard pseudogene nomenclature, with "P" denoting a pseudogene, but there is no evidence that CDONP3 produces a protein or has been implicated in disease mechanisms or drug interactions like its functional counterpart, CDON. Therefore, CDONP3 is not considered a molecular target for therapeutic intervention. No structured or curated biomedical resources (e.g. GeneCards, UniProt) recognize "CDON pseudogene 3" as a gene product with biological activity or clinical relevance. Unless specifically studying pseudogene biology, CDONP3 should not be treated as a drug target, biomarker, or molecular tool in therapeutic contexts. If you believe CDONP3 is functionally relevant for your application, further clarification or re-examination of the gene annotation is recommended, as it currently does not align with recognized protein-coding targets.

Not applicable